Liang EM, Luo HC. Reevaluating the relationship between COVID-19 and type 1 diabetes mellitus: Methodological considerations. World J Diabetes 2025; 16(11): 112939 [DOI: 10.4239/wjd.v16.i11.112939]
Corresponding Author of This Article
Hong-Cheng Luo, MD, Department of Urology, The Eighth Affiliated Hospital of Sun Yat-sen University, No. 3025 Shennan Zhong Road, Futian District, Shenzhen 518033, Guangdong Province, China. drlhc96@163.com
Research Domain of This Article
Endocrinology & Metabolism
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Nov 15, 2025 (publication date) through Nov 14, 2025
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Liang EM, Luo HC. Reevaluating the relationship between COVID-19 and type 1 diabetes mellitus: Methodological considerations. World J Diabetes 2025; 16(11): 112939 [DOI: 10.4239/wjd.v16.i11.112939]
World J Diabetes. Nov 15, 2025; 16(11): 112939 Published online Nov 15, 2025. doi: 10.4239/wjd.v16.i11.112939
Reevaluating the relationship between COVID-19 and type 1 diabetes mellitus: Methodological considerations
Er-Min Liang, Hong-Cheng Luo
Er-Min Liang, Department of Respiratory Medicine, Anting Hospital of Jiading District, Shanghai 201805, China
Hong-Cheng Luo, Department of Urology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518033, Guangdong Province, China
Hong-Cheng Luo, Division of Vascular and Endovascular Surgery, Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong 999077, China
Author contributions: Liang EM wrote the original draft; Luo HC provided supervision, critical revisions, and final approval of the manuscript. All authors have read and approved the final version.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hong-Cheng Luo, MD, Department of Urology, The Eighth Affiliated Hospital of Sun Yat-sen University, No. 3025 Shennan Zhong Road, Futian District, Shenzhen 518033, Guangdong Province, China. drlhc96@163.com
Received: August 11, 2025 Revised: August 25, 2025 Accepted: October 20, 2025 Published online: November 15, 2025 Processing time: 96 Days and 0.8 Hours
Core Tip
Core Tip: Carmon et al’s study suggests a link between the coronavirus disease 2019 (COVID-19) pandemic and rising type 1 diabetes mellitus cases. This letter provides a constructive critique of their methodology. The authors point out that ecological analysis without individual infection data can be misleading, unaddressed confounders and lack of COVID-19 stratification weaken causal inference, and pandemic-related diagnostic delays (reflected in higher diabetic ketoacidosis rates) may have inflated case counts. The authors also caution that biases in viral surveillance data complicate the interpretation of “reduced” non-COVID infections. Addressing these issues with more granular data and analyses will improve future research on the type 1 diabetes mellitus-COVID relationship.
